Kirk Hevener, an assistant professor at ISU-Meridian, is profiled in a March article appearing on the Institute of Translational Health Sciences
Kirk Hevener, an assistant professor of biomedical and pharmaceutical sciences at ISU-Meridian, is profiled in a March article appearing on the Institute of Translational Health Sciences website. The article discusses his research into alternative treatments for Clostridium difficile, the toxin-producing bacterium that causes inflammation in the colon. Read more at https://www.iths.org/blog/news/repurposing-existing-drug-c-difficile-therapy/ .
The Institute--based in Seattle--is a partnership between the University of Washington, Fred Hutchinson Cancer Research Center and Seattle Children's hospital and foundation. The ITHS's mission is to promote the translation of scientific discovery to clinical practice through research and partnerships.